Intracoronary Abciximab in Diabetic STEMI Patients: Questionable Benefit, Proven Harm

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	739-741
Journal	Journal of the American College of Cardiology
Volume	68
Issue number	7
DOIs	https://doi.org/10.1016/j.jacc.2016.06.014
Publication status	Published - 2016

Access to Document

@article{43a688bb594240cb937f29c558366fd1,

title = "Intracoronary Abciximab in Diabetic STEMI Patients: Questionable Benefit, Proven Harm",

author = "Henriques, {Jos{\'e} P. S.} and Kikkert, {Wouter J.}",

year = "2016",

doi = "https://doi.org/10.1016/j.jacc.2016.06.014",

language = "English",

volume = "68",

pages = "739--741",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier USA",

number = "7",

}

TY - JOUR

T1 - Intracoronary Abciximab in Diabetic STEMI Patients: Questionable Benefit, Proven Harm

AU - Henriques, José P. S.

AU - Kikkert, Wouter J.

PY - 2016

Y1 - 2016

U2 - https://doi.org/10.1016/j.jacc.2016.06.014

DO - https://doi.org/10.1016/j.jacc.2016.06.014

M3 - Editorial

C2 - 27515334

SN - 0735-1097

VL - 68

SP - 739

EP - 741

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 7

ER -